Effect and Safety of Prophylactic Parecoxib for Pain Control of Transarterial Chemoembolization in Liver Cancer: A Single-Center, Parallel-Group, Randomized Trial.

Author: GuoNa, KongYanan, LaiJinfa, LiJibin, LiXiaoxian, LyuNing, ZhaoMing

Paper Details 
Original Abstract of the Article :
OBJECTIVE: Pain is one of the most common side effects of transarterial chemoembolization (TACE) in patients with unresectable hepatocellular carcinoma. The goal of this study is to compare the analgesic effect among celecoxib, parecoxib, and oxycodone in patients undergoing TACE. METHODS: This pro...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.jacr.2021.09.029

データ提供:米国国立医学図書館(NLM)

Managing Pain After Transarterial Chemoembolization: A New Approach

This research delves into the world of transarterial chemoembolization (TACE), a procedure used to treat liver cancer. It's like exploring a challenging desert terrain, seeking solutions to a difficult condition. The study investigated the effectiveness of different pain management strategies after TACE, comparing celecoxib, parecoxib, and oxycodone. It's like trying different types of desert plants to find the most effective remedy for a persistent ailment.

The Results: Parecoxib's Superior Pain Relief

The study found that parecoxib was significantly more effective than celecoxib and oxycodone in controlling pain after TACE. This is like discovering a desert plant that offers superior pain relief compared to other options. The researchers also observed that parecoxib was associated with fewer adverse events, making it a preferred choice for pain management after TACE.

Impact on Liver Cancer Treatment: Improving Patient Comfort

This research highlights the importance of effective pain management after TACE, a procedure that can cause significant discomfort. It's like ensuring a caravan has the necessary supplies to endure a difficult journey. The study's findings encourage the use of parecoxib as a priority strategy for TACE-related pain control, potentially improving patient comfort and overall well-being.

Dr. Camel's Conclusion

This research reminds us that even in the harsh desert of cancer treatment, we can find ways to alleviate suffering. It's like discovering a hidden oasis, offering respite from pain and discomfort. The study's findings suggest that parecoxib is a valuable tool for pain management after TACE, providing a more effective and well-tolerated solution than existing options. It's a reminder that even in the most challenging of environments, we can strive to improve patient care and make a difference.

Date :
  1. Date Completed 2022-03-02
  2. Date Revised 2022-03-02
Further Info :

Pubmed ID

34736908

DOI: Digital Object Identifier

10.1016/j.jacr.2021.09.029

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.